Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesis. We previously mapped a gene that predisposes to multiple fibroids, cutaneous leiomyomata and renal cell carcinoma to chromosome 1q42.3-q43 (refs 4-6). Here we show, through a combination of mapping critical recombinants, identifying individuals with germline mutations and screening known and predicted transcripts, that this gene encodes fumarate hydratase, an enzyme of the tricarboxylic acid cycle. Leiomyomatosis-associated mutations are predicted to result in absent or truncated protein, or substitutions or deletions of highly conserved amino acids. Activity of fumarate hydratase is reduced in lymphoblastoid cells from individuals with leiomyomatosis. This enzyme acts as a tumor suppressor in familial leiomyomata, and its measured activity is very low or absent in tumors from individuals with leiomyomatosis. Mutations in FH also occur in the recessive condition fumarate hydratase deficiency, and some parents of people with this condition are susceptible to leiomyomata. Thus, heterozygous and homozygous or compound heterozygous mutants have very different clinical phenotypes. Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumor.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“germline mutations in FH cause hereditary leiomyomatosis and renal cell cancer (HLRCC) (7).”
From Accumulation of Krebs cycle intermediates and over-expression of HIF1α in tumours which result from germline FH and SDH mutations (2005) · cites this paper as [7]
In the citing paper
“Familial cancer syndromes caused by fumarate hydratase (FH) or succinate dehydrogenase (SDH) deletion suggest that these TCA enzymes can behave as classical tumor suppressors.”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Tomlinson et al., 2002
In the citing paper
“Similarly, germline mutations in the broadly expressed enzyme fumarate hydratase (FH) cause hereditary leiomyomatosis and renal cell carcinoma, a familial syndrome of uterine and cutaneous leiomyomas and kidney cancer, without susceptibility to more common tumors (11).”
From Metabolic reprogramming and cancer progression (2020) · cites this paper as [11]
In the citing paper
“In 2001, mutation of fumarate hydratase leading to its inactivation was discovered in renal cell cancer129. Mutation of this enzyme leads to fumarate accumulation not only in skin cancer and uterine leiomyomas but also in breast, bladder, and Leydig cell tumors130.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [130]
In the citing paper
“Consistently, heterozygous germline mutations in genes encoding the TCA cycle enzymes involved in the breakdown of these metabolites—SDH and FH—have been shown to facilitate the pathogenesis of certain rare cancers (e.g., paragangliomas) and inherited cancer-predisposition syndromes (181, 182, 183).”
From Regulation and function of the mammalian tricarboxylic acid cycle (2023) · cites this paper as [183]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Mutations in SDHD , a Mitochondrial Complex II Gene, in Hereditary Paraganglioma
Baysal, B. E., Ferrell, R. E., Willett-Brozick, J. E., Lawrence, E. C., Myssiorek, D., Bosch, A., Mey, A. V. D., Taschner, P. E. M., Rubinstein, W. S., Myers, E. N., et al. (2000) · Science · doi:10.1126/science.287.5454.848 · Cited by 1,638 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultAstuti, D., Latif, F., Dallol, A., Dahia, P. L. M., Douglas, F., George, E., Sköldberg, F., Husebye, E. S., Eng, C., & Maher, E. R. (2001) · The American Journal of Human Genetics · doi:10.1086/321282 · Cited by 1,087 · cited 1×
“Our results provide clues to the pathogenesis of fibroids and emphasize the importance of mutations of housekeeping and mitochondrial proteins in the pathogenesis of common types of tumo”
ResultMutations in SDHC cause autosomal dominant paraganglioma, type 3
Niemann, S., & Müller, U. (2000) · Nature Genetics · doi:10.1038/81551 · Cited by 875
Inherited susceptibility to uterine leiomyomas and renal cell cancer
Launonen, V., Vierimaa, O., Kiuru, M., Isola, J., Roth, S., Pukkala, E., Sistonen, P., Herva, R., & Aaltonen, L. A. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051633798 · Cited by 669
Fumarase C, the stable fumarase of Escherichia coli, is controlled by the soxRS regulon.
Liochev, S. I., & Fridovich, I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5892 · Cited by 239
The VHL tumour-suppressor gene paradigm
Kaelin, W. G., & Maher, E. R. (1998) · Trends in Genetics · doi:10.1016/s0168-9525(98)01558-3 · Cited by 213 · cited 1×
“, individuals with von Hippel–Lindau syndrome are predisposed to both phaeochromocytomas and renal carcinoma”
BackgroundKiuru, M., Launonen, V., Hietala, M., Aittomäki, K., Vierimaa, O., Salovaara, R., Arola, J., Pukkala, E., Sistonen, P., Herva, R., et al. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61757-9 · Cited by 209
Bourgeron, T., Chretien, D., Poggi-Bach, J., Doonan, S., Rabier, D., Letouzé, P., Munnich, A., Rötig, A., Landrieu, P., & Rustin, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117261 · Cited by 160
Alam, N. A., Bevan, S., Churchman, M., Barclay, E., Barker, K., Jaeger, E. E. M., Nelson, H. M., Healy, E., Pembroke, A. C., Friedmann, P. S., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/320124 · Cited by 160
Familial predisposition to uterine leiomyomas
Vikhliaeva, E. M., Сагдуллаевна, Х. З., & Nd, F. (1995) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(95)02533-i · Cited by 152 · cited 1×
“gif" NDATA ITEM> ]> Uterine leiomyomata (fibroids) are common and clinically important tumors, but little is known about their etiology and pathogenesi”
Background
Cited by
Items 801–900 of 1,000
Wilms tumour as a possible early manifestation of hereditary leiomyomatosis and renal cell cancer?
Badeloe, S., van Spaendonck‐Zwarts, K. Y., Steensel, M. A. M. V., Marion, A. M. W. V., van Essen, A. J., Jonkman, M. F., Steijlen, P. M., Poblete‐Gutiérrez, P., van Geel, M., & Frank, J. (2009) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.09000.x · Cited by 19
Rao, Q., Xia, Q., Liang Cheng, C., & Zhou, X. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.1000-9604.2016.01.03 · Cited by 19
Genetic basis of eugonadal and hypogonadal female reproductive disorders
Trofimova, T., Lizneva, D., Сутурина, Л. В., Walker, W., Chen, Y.-H., Azziz, R., & Layman, L. C. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2017.05.003 · Cited by 20
Jain, A., Bakhshi, S., Thakkar, H., Gerards, M., & Singh, A. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26874 · Cited by 19
Molecular differential diagnosis of uterine leiomyomas and leiomyosarcomas
Mas, A., & Simón, C. (2018) · Biology of Reproduction · doi:10.1093/biolre/ioy195 · Cited by 20
Yu, H., Wang, F., Fang, Y., Zeng, Z.-L., Wang, Y., Lu, Y., Jin, Y., Wang, D., Qiu, M., Pu, H., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1652-8 · Cited by 19
RetractedPheochromocytoma/Paraganglioma: Is This a Genetic Disorder?
Fishbein, L. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1184-y · Cited by 22
Nitrogen Trapping as a Therapeutic Strategy in Tumors with Mitochondrial Dysfunction
Madala, H. R., Helenius, I. T., Zhou, W., Mills, E. L., Zhang, Y., Liu, Y., Metelo, A. M., Kelley, M. L., Punganuru, S. R., Kim, K. B., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-20-0246 · Cited by 21
Äyräväinen, A., Pasanen, A. M., Ahvenainen, T., Heikkinen, T., Pakarinen, P. I., Härkki, P., & Vahteristo, P. (2020) · Human Reproduction · doi:10.1093/humrep/deaa187 · Cited by 19
Toss, A., Quarello, P., Mascarin, M., Banna, G. L., Zecca, M., Cinieri, S., Peccatori, F. A., & Ferrari, A. (2022) · Current Oncology Reports · doi:10.1007/s11912-022-01213-3 · Cited by 20
Sandhu, I. S., Maksim, N. J., Amouzougan, E. A., Gallion, B. W., Raviele, A. L. J., & Ooi, A. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150041 · Cited by 20
Mitochondrial and Nuclear Genes of Mitochondrial Components in Cancer
Kirches, E. (2009) · Current Genomics · doi:10.2174/138920209788488517 · Cited by 21
“Germline mutations clustering in the aminoterminal region before codon 250 were however more recently associated with an autosomal dominant tumor syndrome causing uterine and skin leimyomata, as well as papillary renal cell cancer [53].”
BackgroundModular Synthesis of Cell-Permeating 2-Ketoglutarate Esters
Zengeya, T. T., Kulkarni, R. A., & Meier, J. L. (2015) · Organic Letters · doi:10.1021/acs.orglett.5b00737 · Cited by 19
Metabolic Alterations at the Crossroad of Aging and Oncogenesis
Raffaghello, L., & Longo, V. D. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.01.003 · Cited by 19
“Heterozygous FH mutations predispose to multiple cutaneous and uterine leiomyomas, hereditary leiomyomatosis, renal cell cancer, breast, bladder, as well as Leydig cell tumors (Carvajal-Carmona et al., 2006; Lehtonen et al., 2006; Tomlinson et al., 2002).”
BackgroundPalu, R. A. S., Ong, E., Stevens, K., Chung, S., Owings, K. G., Goodman, A. G., & Chow, C. Y. (2019) · G3 Genes Genomes Genetics · doi:10.1534/g3.119.400722 · Cited by 19
Campione, E., Terrinoni, A., Orlandi, A., Codispoti, A., Melino, G., Bianchi, L., Mazzotta, A., Garaci, F. G., Ludovici, A., & Chimenti, S. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700851 · Cited by 21
Uitto, J., Pulkkinen, L., & Ringpfeil, F. (2002) · Journal of Investigative Dermatology Symposium Proceedings · doi:10.1046/j.1523-1747.2002.19637.x · Cited by 20
Ricketts, C. J., Killian, J. K., Vocke, C. D., Wang, Y., Merino, M. J., Meltzer, P. S., & Linehan, W. M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0278108 · Cited by 20
Ferroptosis: An Emerging Target for Bladder Cancer Therapy
Shan, Z., Tang, W., Shi, Z., & Shan, T. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45100517 · Cited by 18
Rewiring of RNA methylation by the oncometabolite fumarate in renal cell carcinoma
Fitzsimmons, C. M., Mandler, M. D., Lunger, J. C., Chan, D., Maligireddy, S. S., Schmiechen, A. C., Gamage, S. T., Link, C. N., Jenkins, L. M. M., Chan, K. C., et al. (2024) · NAR Cancer · doi:10.1093/narcan/zcae004 · Cited by 19
An update on the management of uterine fibroids: personalized medicine or guidelines?
Mensión, E., Calaf, J., Chapron, C., Dolmans, M., Donnez, J., Marcellin, L., Petraglia, F., Vannuccini, S., & Carmona, F. (2024) · Journal of Endometriosis and Uterine Disorders · doi:10.1016/j.jeud.2024.100080 · Cited by 23
Ritzmann, S., Hanneken, S., Neumann, N. J., Ruzicka, T., & Kruse, R. (2005) · Dermatology · doi:10.1159/000089031 · Cited by 18
Changes in mitochondrial DNA alter expression of nuclear encoded genes associated with tumorigenesis
Jandová, J., Janda, J., & Sligh, J. E. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.06.006 · Cited by 21
“mtDNA mutations have been identified in epithelial tumors, cutaneous tumors, tumors of musculoskeletal, central nervous, and endocrine system [4-12; 3; 13-17].”
BackgroundMultiple painful cutaneous nodules and renal mass
Rothman, A., Glenn, G. M., Choyke, L. T., Srinivasan, R., Linehan, W. M., & Cowen, E. W. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.026 · Cited by 18
Inflammatory stress and sarcomagenesis: a vicious interplay
Radons, J. (2013) · Cell Stress and Chaperones · doi:10.1007/s12192-013-0449-4 · Cited by 20
“Other risk factors include heterozygous germline mutations in the fumarate hydratase gene predisposing to hereditary leiomyomatosis and renal cell cancer (HLRCC; Tomlinson et al. 2002).”
BackgroundOncometabolite Accumulation and Epithelial-to-Mesenchymal Transition: The Turn of Fumarate
Janin, M., & Esteller, M. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.09.020 · Cited by 20
“In the early 2000s, inactivating germline mutations in the gene encoding the enzyme fumarate hydratase (FH) were described to predispose individuals to hereditary leiomyomas and papillary renal cancers (Tomlinson et al., 2002).”
BackgroundYonese, I., Ito, M., Takemura, K. N., Kamai, T., & Koga, F. (2020) · Journal of Kidney Cancer and VHL · doi:10.15586/jkcvhl.2020.148 · Cited by 18
Control of topoisomerase II activity and chemotherapeutic inhibition by TCA cycle metabolites
Lee, J. H., Mosher, E. P., Lee, Y., Bumpus, N. N., & Berger, J. M. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.08.014 · Cited by 18
Mesenchymal Tumors of the Uterus
Oliva, E., Zaloudek, C. J., & Soslow, R. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-46334-6_10 · Cited by 19
Multiple cutaneous and uterine leiomyomatosis syndrome: a review.
Choudhary, S., McLeod, M. P., Torchia, D., & Romanelli, P. (2013) · Europe PMC (PubMed Central) · Cited by 18
Furge, K. A., Dykema, K. J., Petillo, D., Westphal, M., Zhang, Z., Kort, E. J., & Teh, B. T. (2012) · Canadian Urological Association Journal · doi:10.5489/cuaj.64 · Cited by 18
Mäkinen, N., Heinonen, H.-R., Sjöberg, J., Taipale, J., Vahteristo, P., & Aaltonen, L. A. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.138 · Cited by 18
“None of the samples displayed a mutation in MED12 exon 2 or in the coding regions of fumarate hydratase (FH), a gene which has previously been associated with the predisposition to leiomyomas (Tomlinson et al, 2002).”
BackgroundThe growing family of hereditary renal cell carcinoma
Richard, S., Lidereau, R., & Giraud, S. (2004) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfh535 · Cited by 18
Epidemiology of Renal Cell Carcinoma
Narayanan, S., Patel, P. H., Fan, A. C., & Srinivas, S. (2015) · Springer eBooks · doi:10.1007/978-3-319-17903-2_1 · Cited by 18
Michaeli, O., Kim, S. Y., Mitchell, S. G., Jongmans, M. C. J., Wasserman, J. D., Perrino, M. R., Das, A., MacFarland, S. P., Scollon, S., Greer, M. C., et al. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-24-2171 · Cited by 20
Jokinen, V., Mehine, M. M., Reinikka, S., Khamaiseh, S., Ahvenainen, T., Äyräväinen, A., Härkki, P., Bützow, R. C., Pasanen, A. M., & Vahteristo, P. (2022) · Genes Chromosomes and Cancer · doi:10.1002/gcc.23088 · Cited by 19
Heinritz, W., Paasch, U., Sticherling, M., Wittekind, C., Simon, J. C., Froster, U., & Renner, R. (2007) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2007.00396.x · Cited by 18
Diagnosis and Management of Hereditary Renal Cell Cancer
Menko, F. H., & Maher, E. R. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-29998-3_6 · Cited by 20
Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report
Chan, M., Barnicoat, A. J., Mumtaz, F., Aitchison, M., Side, L. E., Brittain, H. K., Bates, A. W., & Gale, D. P. (2017) · BMC Medical Genetics · doi:10.1186/s12881-017-0436-1 · Cited by 17
Recent advances in the systemic treatment of metastatic non‐clear cell renal cell carcinomas
Ito, K. (2019) · International Journal of Urology · doi:10.1111/iju.14027 · Cited by 17
Furuya, M., Iribe, Y., Nagashima, Y., Kambe, N., Ohe, C., Kinoshita, H., Sato, C., Kishida, T., Okubo, Y., Numakura, K., et al. (2020) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2020-206548 · Cited by 17
Towards the routine use of in silico screenings for drug discovery using metabolic modelling
Bintener, T., Pacheco, M. P., & Sauter, T. (2020) · Biochemical Society Transactions · doi:10.1042/bst20190867 · Cited by 18
Genetic alterations in uterine fibroids – a new direction for pharmacological intervention?
Markowski, D. N., Holzmann, C., & Bullerdiek, J. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1075510 · Cited by 17
“In a rare subtype of UL the tumors develop in women who have germline mutations of the gene-encoding fumarate hydratase (FH) [54].”
BackgroundNon-clear cell advanced kidney cancer
Sánchez, P., Calvo, E., & Durán, I. (2010) · Anti-Cancer Drugs · doi:10.1097/01.cad.0000390767.85658.83 · Cited by 17
Casting an eye on the Krebs cycle
Münnich, A. (2008) · Nature Genetics · doi:10.1038/ng1008-1148 · Cited by 20
Novel ways to target brain tumour metabolism
Stieber, D., Rahim, S. A. A., & Niclou, S. P. (2011) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2011.588211 · Cited by 17
“Similarly, mutations in the enzyme fumarate hydratase results in multiple cutaneous leiomyomas and in certain cases aggressive renal cell carcinoma [57].”
BackgroundTranscriptional regulation of metabolism in disease: From transcription factors to epigenetics
Hawkins, L. J., Al-attar, R., & Storey, K. B. (2018) · PeerJ · doi:10.7717/peerj.5062 · Cited by 21
Synthetically Lethal Interactions of Heme Oxygenase-1 and Fumarate Hydratase Genes
Podkalicka, P., Mucha, O., Kruczek, S., Biela, A., Andrysiak, K., Stępniewski, J., Mikulski, M., Gałȩzowski, M., Sitarz, K. S., Brzózka, K. D., et al. (2020) · Biomolecules · doi:10.3390/biom10010143 · Cited by 17
Intracellular Succinylation of 8-Chloroadenosine and Its Effect on Fumarate Levels
Dennison, J. B., Ayres, M., Kaluarachchi, K. K., Plunkett, W. K., & Gandhi, V. V. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.085803 · Cited by 17
The role of hypoxia inducible factor-1 in cell metabolism – a possible target in cancer therapy
Aiba, R. S. B., Dimova, E. Y., Görlach, A., & Kietzmann, T. (2006) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.10.4.583 · Cited by 19
“This enhanced HIF-1α stability might be one of the reasons for the inherited cancer syndromes observed in clinical cases characterised with SDH and FH mutations [115-120].”
BackgroundMetabolomics in paraganglioma: applications and perspectives from genetics to therapy
Richter, S., Garrett, T. J., Bechmann, N., Clifton-Bligh, R. J., & Ghayee, H. K. (2023) · Endocrine Related Cancer · doi:10.1530/erc-22-0376 · Cited by 16
Impact of Opioids on Cellular Metabolism: Implications for Metabolic Pathways Involved in Cancer
Tarazi, D., & Maynes, J. T. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15092225 · Cited by 17
“Identification of mutations in isocitrate dehydrogenase, succinate dehydrogenase, fumarase, and malate dehydrogenase (MD) in a variety of cancer types has redirected attention to the role of the TCA in reprogramming tumor metabolism [157–159].”
Chen, Y. (2023) · Advances in Anatomic Pathology · doi:10.1097/pap.0000000000000426 · Cited by 16
Kuwada, M., Chihara, Y., Lou, Y., Torimoto, K., Kagebayashi, Y., Tamura, K., Shuin, T., Fujimoto, K., Kuniyasu, H., & Samma, S. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-203 · Cited by 16
Metabolic alteration in tumorigenesis
Yang, H., Xiong, Y., & Guan, K. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4549-2 · Cited by 18
Hereditary renal cell carcinoma: genetics, clinical features, and surgical considerations
Byler, T. K., & Bratslavsky, G. (2014) · World Journal of Urology · doi:10.1007/s00345-014-1287-4 · Cited by 17
“Subsequent mapping studies showed 1q42 and mutation in the fumarate hydratase gene (FH) [30].”
BackgroundMadhu, B., Narita, M., Jauhiainen, A., Menon, S., Stubbs, M., Tavaré, S., Narita, M., & Griffiths, J. R. (2015) · Metabolomics · doi:10.1007/s11306-015-0838-z · Cited by 16
“Surprisingly, FH, a TCA cycle gene that has oncogenic effects when mutated (Tomlinson et al. 2002), retained its negative correlation with PHGDH and ASNS (both from amino acid pathways) and lost its negative correlation with PSAT1 (amino acid pathway) and PYCR1 (TCA cycle) after E1A/RAS…”
BackgroundBulku, A., Weaver, T. M., & Berkmen, M. B. (2018) · The Open Biochemistry Journal · doi:10.2174/1874091x01812010001 · Cited by 16
Shyu, I., Mirsadraei, L., Wang, X., Robila, V., Mehra, R., McHugh, J. B., Chen, Y., Udager, A. M., Gill, A. J., Liang Cheng, C., et al. (2018) · Cancer Cytopathology · doi:10.1002/cncy.22071 · Cited by 16
“3-q43.(2) The RCCs arising in this syndrome exhibit variable morphology with a high multiplicity of patterns(3) and arise across a wide age range.”
BackgroundPagani, T. D., Guimarães, A. C. R., Waghabi, M. C., Corrêa, P. R., Kalume, D. E., Berrêdo‐Pinho, M., Degrave, W., & Mendonça-Lima, L. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00716 · Cited by 16
Non-canonical roles for metabolic enzymes and intermediates in malignant progression and metastasis
Williams, D., & Fingleton, B. (2019) · Clinical & Experimental Metastasis · doi:10.1007/s10585-019-09967-0 · Cited by 16
Hereditary Leiomyomatosis and Renal Cell Cancer
Hansen, A., Chayed, Z., Pallesen, K. A. U., Vasilescu, I., & Bygum, A. (2019) · Acta Dermato Venereologica · doi:10.2340/00015555-3366 · Cited by 17
“se/acta or fumarase, which catalyses the conversion of fumarate to malate in the tricarboxylic acid cycle (TCA) (20).”
BackgroundInfluentialTNFAIP8 drives metabolic reprogramming to promote prostate cancer cell proliferation
Niture, S. K., Lin, M., Odera, J. O., Moore, J. T., Zhe, H., Chen, X. L., Suy, S., Collins, S. P., & Kumar, D. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105885 · Cited by 19
Al-Shinnag, M., Fan, H. M., Susman, R., Wakeling, J., Gustafson, S., Wood, S., & Mallett, A. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.738822 · Cited by 16
Reproductive Functions of the Mitochondrial Progesterone Receptor (PR-M)
Shaia, K. L., Harris, B. S., Selter, J. H., & Price, T. M. (2022) · Reproductive Sciences · doi:10.1007/s43032-022-01092-w · Cited by 16
“Fibroids arise from mutations, such as MED12 [54], high mobility group proteins HMGA2 and HMGA1 [55], and fumarate hydratase [56] in myometrial stem cells, referred to as leiomyoma-side-population cells (LMSP) by the original identification with flow cytometry characteristics.”
BackgroundJandová, J., Shi, M., Norman, K. G., Stricklin, G. P., & Sligh, J. E. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.11.010 · Cited by 16
Fumarase Deficiency in Dichorionic Diamniotic Twins
Tregoning, S., Salter, W., Thorburn, D. R., Durkie, M., Panayi, M., Wu, J. Y., Easterbrook, A., & Coman, D. J. (2013) · Twin Research and Human Genetics · doi:10.1017/thg.2013.72 · Cited by 16
“The FH gene has also been shown to act as a tumor suppressor gene, predisposing carriers to autosomal dominant benign fibroid tumors of skin, uterus, hereditary leiomyomatosis, and renal cell carcinoma (HLRCC), as well as multiple cutaneous and uterine leiomyosarcoma (MCUL) later in life (Deschauer et al., 2006; Tomli…”
BackgroundHuang, K. T., Dobrovic, A., & Fox, S. B. (2009) · BMC Research Notes · doi:10.1186/1756-0500-2-194 · Cited by 18
“Mutations in the genes coding for SDH subunits B, C and D predispose to familial paragangliomas and phaeochromocytomas [11,21,22], and mutations in FH cause hereditary leiomyomatosis and renal cell carcinomas [23].”
BackgroundA computational analysis of S-(2-succino)cysteine sites in proteins
Miglio, G., Sabatino, A., Veglia, E., Giraudo, M. T., Beccuti, M., & Cordero, F. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.11.003 · Cited by 17
Kamai, T., Abe, H., Arai, K., Murakami, S., Sakamoto, S., Kaji, Y., & Yoshida, K. (2016) · BMC Cancer · doi:10.1186/s12885-016-2272-7 · Cited by 16
Kopp, R. P., Stratton, K. L., Glogowski, E., Schrader, K. A., Rau‐Murthy, R., Russo, P., Coleman, J., & Offit, K. (2017) · Cancer · doi:10.1002/cncr.30605 · Cited by 17
“Diagnostic features of HLRCC include uterine fibroids, renal tumors, and cutaneous leiomyomas; patients may have a family history of any of these manifestations, and the diagnosis is confirmed by tests for FH mutations.(1,2) HLRCC is most often diagnosed through the identification of cutaneous leiomyomas.”
Christensen, C. L., & Choy, F. Y. M. (2017) · Diseases · doi:10.3390/diseases5010006 · Cited by 20
“If Cas9 cleavage is triggered in an unintended location, chromosomal aberrations [93], the down-regulation of a tumor-suppressor gene or the up-regulation of an oncogene [94], or an unforeseen deleterious mutation in a housekeeping gene [95] could be realized post-reintroduction of the edited cells to a patient, where…”
BackgroundPelvic and pulmonary benign metastasizing leiomyoma: A case report
Bakkensen, J. B., Samore, W. R., Bortoletto, P. E., Morton, C. C., & Anchan, R. M. (2018) · Case Reports in Women s Health · doi:10.1016/j.crwh.2018.e00061 · Cited by 16
Fumarate Metabolic Signature for the Detection of Reed Syndrome in Humans
Casey, R. T., McLean, M. A., Challis, B., McVeigh, T. P., Warren, A. Y., Mendil, L., Houghton, R., de Sanctis, S., Kosmoliaptsis, V., Sandford, R. N., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1729 · Cited by 16
“The clinical phenotype associated with FHmutations is hereditary leiomyomas and renal cell carcinoma syndrome (HLRCC) or Reed syndrome and comprises cutaneous and uterine leiomyomas, type 2 papillary RCCs (5, 8), and occasionally phaeochromocytomas/paragangliomas (6).”
BackgroundTeleological role of L-2-hydroxyglutarate dehydrogenase in the kidney
Brinkley, G. J., Nam, H., Shim, E., Kirkman, R. L., Kundu, A., Karki, S., Heidarian, Y., Tennessen, J. M., Liu, J., Locasale, J. W., et al. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.045898 · Cited by 17
Roy, D., Felty, Q., Narayan, S., & Jayakar, P. (2006) · Frontiers in bioscience · doi:10.2741/2056 · Cited by 16
“Recently, mutations in another mitochondrial Krebs cycle protein, fumarase, have been associated with the development of uterine fibroids, skin leiomyomata and renal cell cancer (75).”
BackgroundCatherino, W. H., Mayers, C. M., Mantzouris, T., Armstrong, A. Y., Linehan, W. M., & Segars, J. H. (2007) · Fertility and Sterility · doi:10.1016/j.fertnstert.2006.11.198 · Cited by 16
Hereditary leiomyomatosis and renal cell cancer (HLRCC): Case series and review of the literature
Yu, Y., Zheng, M., Zhu, W., Zhao, F., Guan, B., Shen, Q., Yang, F., He, Q., & Li, X. (2021) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2021.07.026 · Cited by 15
Molecular and therapeutic landscape of non-clear cell renal carcinoma
Nepali, P. R., Eraky, A., Okhawere, K. E., Dogra, N., Mehrazin, R., Badani, K. K., & Kyprianou, N. (2025) · Nature Reviews Urology · doi:10.1038/s41585-025-01056-0 · Cited by 16
“…HLRCC) is a rare genetic type of nccRCC characterized by smooth muscle growths (known as leiomyomas) on the skin and uterus and germline mutations in the gene encoding FH, an enzyme of the tricarboxylic acid cycle, resulting in the absence or severe reduction of the activity of this enzyme 3,100 .”
The deep end of the metabolite pool: influences on epigenetic regulatory mechanisms in cancer
Nordgren, K. K. S., & Skildum, A. J. (2014) · European Journal of Clinical Investigation · doi:10.1111/eci.12361 · Cited by 16
Nuevos patrones epidemiológicos y factores de riesgo en cáncer renal
Curado, F. J. A., Campos-Hernández, J. P., Castro, R. P., Carazo, J. L. C., López, J. C. R., Jiménez, F. V., & Tapia, M. J. R. (2009) · Actas Urológicas Españolas · doi:10.1016/s0210-4806(09)74178-6 · Cited by 15
Maxwell, P. H. (2011) · The Journal of Pathology · doi:10.1002/path.2950 · Cited by 15
Update on the Biology and Management of Renal Cell Carcinoma
Dutcher, J. P. (2018) · Journal of Investigative Medicine · doi:10.1136/jim-2018-000918 · Cited by 15
Zhou, X., Qiu, S., Jin, D., Jin, K., Zheng, X.-N., Yang, L., & Wei, Q. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.569884 · Cited by 14
Ahvenainen, T., Khamaiseh, S., Alkodsi, A., Mehine, M. M., Nevala, R., Äyräväinen, A., Bützow, R. C., & Vahteristo, P. (2022) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2022.104760 · Cited by 15
Genetic, metabolic and immunological features of cancers with NRF2 addiction
Kitamura, H., Takeda, H., & Motohashi, H. (2022) · FEBS Letters · doi:10.1002/1873-3468.14458 · Cited by 16
Ueno, D., Vasquez, J. C., Sule, A. D., Liang, J., Doorn, J. V., Sundaram, R. K., Friedman, S., Caliliw, R., Ohtake, S., Bao, X., et al. (2022) · Oncotarget · doi:10.18632/oncotarget.28273 · Cited by 16
Metabolic analysis of 13C‐labeled pyruvate for noninvasive assessment of mitochondrial function
Wu, I., Ohsawa, I., Fuku, N., & Tanaka, M. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05636.x · Cited by 15
Wheeler, K. C., Warr, D. J., Warsetsky, S. I., & Barmat, L. I. (2015) · Fertility and Sterility · doi:10.1016/j.fertnstert.2015.09.034 · Cited by 15
Rongioletti, F., Fausti, V., Ferrando, B., Parodi, A., Mandich, P., & Pasini, B. (2010) · Dermatology · doi:10.1159/000321336 · Cited by 15
Calonje, E. J., Brenn, T., & Lazar, A. J. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-5649-2.00035-4 · Cited by 15
Quade, B. J., & Robboy, S. J. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-07477-6.50023-8 · Cited by 15
Les cancers du rein héréditaires vus par le pathologiste en 2020
Verkarre, V., Morini, A., Denize, T., Ferlicot, S., & Richard, S. (2020) · Annales de Pathologie · doi:10.1016/j.annpat.2020.02.022 · Cited by 15
Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma
Kamai, T., Higashi, S., Murakami, S., Arai, K., Namatame, T., Kijima, T., Abe, H., Jamiyan, T., Ishida, K., Shirataki, H., et al. (2021) · Cancer Science · doi:10.1111/cas.14977 · Cited by 15
Hereditary cancer syndromes of the skin
Somoano, B., Niendorf, K. B., & Tsao, H. (2005) · Clinics in Dermatology · doi:10.1016/j.clindermatol.2004.09.012 · Cited by 16
Hwang, J. J., Uchio, E., Linehan, W. M., & Walther, M. M. (2003) · Urologic Clinics of North America · doi:10.1016/s0094-0143(03)00054-5 · Cited by 15
Therapeutic Options for Variant Renal Cancer
Stadler, W. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-040032 · Cited by 15
Eng, C. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn263 · Cited by 16
Najera, S. S., Ricketts, C. J., Schmidt, L. S., Medina, J. I., Saito, K., Ileva, L. V., Brender, J., James, A. E., Peer, C. J., Gouker, B. A., et al. (2024) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-24-0225 · Cited by 14
Targeting immuno-metabolism to improve anti-cancer therapies
Beezhold, K., & Byersdorfer, C. A. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.11.005 · Cited by 14
“Future insights into the role of TCA cycle enzymes and T cell function may result from detailed observation of individuals with germline mutations in genes such as fumarase [20] and succinate dehydrogenase [21], or from the study of T cell function following exposure to specific enzyme inhibitors.”
Background
Metadata
- Authors
- The Multiple Leiomyoma Consortium
- Venue
- Nature Genetics
- Published
- 2002-02-25
- Volume
- 30
- Issue
- 4
- Pages
- 406-410
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1967291345
- Cited by
- 1,635
- References
- 17
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 64 · 2023: 57 · 2022: 65 · 2021: 80 · 2020: 93 · 2019: 86 · 2018: 81 · 2017: 90 · 2016: 106 · 2015: 89 · 2014: 85 · 2013: 82 · 2012: 82
- FWCI
- 56.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Discovery Research Portal (University of Dundee) (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- U.S. Public Health Service (U59309)
- Topics
- Health Sciences › Medicine › Obstetrics and Gynecology › Uterine Myomas and Treatments
- Health Sciences › Medicine › Genetics (clinical) › Tuberous Sclerosis Complex Research
- Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
- Keywords
- fumarate hydratase, FH gene, germline mutations, uterine fibroids, cutaneous leiomyoma, papillary renal cell carcinoma, cancer susceptibility, tumor suppressor, fumarate hydratase deficiency, compound heterozygosity, TCA cycle, fibroid pathogenesis
- MeSH terms
- Alleles, Carcinoma, Papillary, Carcinoma, Renal Cell, Chromosomes, Human, Pair 1, Exons, Female, Fumarate Hydratase, Genes, Dominant, Genetic Markers, Humans, Kidney Neoplasms, Leiomyoma, Male, Mutation, Pedigree, Recombination, Genetic, Uterine Neoplasms, Gene Deletion, In Situ Hybridization, Fluorescence, Sequence Analysis, DNA, Germ-Line Mutation, Leiomyoma, Epithelioid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.